Agenda - Day Two: Tuesday, November 17

Showing 1 of 1 Streams

Registration

08:00 - 08:30

Continental Breakfast and Registration

Showing 1 of 1 Streams

Copay, Reimbursement and Access Strategies

08:30 - 08:45

Chairperson Review of Day 1

Chris Dowd - Senior Vice President, ConnectiveRx

08:45 - 09:30

Access Unlocked – The New Era of Patient Discovery, Trust and Action

Divya Iyer - Senior Vice President, Go-to-Market Strategy, GoodRx
Jessica Meyer - Head of Market Access & Trade Relations, Viatris
Nate Hearn - HCP/Patient Engagement Commercial Operations Lead, Pfizer

09:30 - 10:30

The Inflation Reduction Act in Motion – What’s Working, What’s Not and What’s Next?

Kirsten Axelsen - Independent Consultant, Grasshopper Industries
Marc Appel - Founder, Orange Grove Bio, Entrepreneur in Residence, Yale Ventures
Joan Rizal - Senior Counsel, Amneal Pharmaceuticals

Showing 1 of 1 Streams

Networking Break

10:30 - 11:00

Networking and Refreshment Break

Showing 1 of 1 Streams

Copay, Reimbursement and Access Strategies

11:00 - 11:30

Blueprint for the Future – Building Scalable, Compliant Copay Programs in a Shifting Landscape

Tate Williams - Senior Director, Affordability and Insights, CoverMyMeds

11:30 - 12:15

Policy and Market Access Updates – Accumulators, Maximizers, AFPs and Emerging Cost-Shifting Strategies

Stephanie Hengst - Manager, Policy and Research, The Aids Institute
Carl Schmid - Executive Director, HIV+Hepatitis Policy Institute

Showing 2 of 2 Streams

Networking Break

Executive Session

12:15 - 13:30

Networking Luncheon

12:15 - 13:30

Closed Door Luncheon on Accumulators, Maximizers and Alternative Funding Programs

Richard Fahrer - Director, Oncology Patient Solutions & Alliances, Pfizer
Meredith McDonald - Director, Patient Access, Exelixis Inc
Doug Gabbard, MBA - President and Founder, Prescriptive Path

Showing 1 of 1 Streams

Copay, Reimbursement and Access Strategies

13:30 - 14:15

Enforcement Update – DOJ Insights on Actions and Trends in the Copay and Patient Services Space

Kirsten Axelsen - Independent Consultant, Grasshopper Industries
David Blank - Partner, Arnall Golden Gregory LLP, Former Senior Counsel, HHS/OIG
Matthew E. K. Howatt - Former Assistant United States Attorney, Eastern District of Pennsylvania; Current Senior Director, Head of Legal Affairs, Sun Pharmaceutical Industries, Inc.

14:15 - 15:00

Mastering Copay Communication — The Importance of Proactive vs Reactive Communication

Connie Frangakis - Associate Director, Operational Excellence, Patient Services, Kyowa Kirin, Inc.

Showing 1 of 1 Streams

Networking Break

15:00 - 15:30

Networking and Refreshment Break

Showing 1 of 1 Streams

Copay, Reimbursement and Access Strategies

15:30 - 16:15

Maximizing Success – The Role of Field Reimbursement Services in Launch Strategy and Beyond

Aimee Crawley - National Sales Director, CoverMyMeds
Brian Wyer - Director of Sales Support, CoverMyMeds

16:15 - 17:00

Navigating Specialty Pharmacy in Rare Diseases – Optimizing Access and Market Strategy

Usha Roy - Senior Director, Patient Support and Reimbursement, MASA, Azurity Pharmaceuticals
Sheila Bhattacharya - Former Vice President, Market Access and Strategic Accounts, Azurity Pharmaceuticals

17:00 - 17:30

The Big Beautiful Bill and its Impact on Copay Programs and Patient Access

Mike Eging - Leadership Team, Rare Access Project

17:30 - 18:00

Beyond Coverage – Redesigning Insurance to Better Meet Patient Need

Ulrich Neumann - Director, Access & Policy Research, Johnson & Johnson

Showing 1 of 1 Streams

Networking Break

18:00 - 19:00

End of Day 2 and Networking Reception

Day Two: Tuesday, November 17Tuesday, 17 November 2026

Get the Latest Event Updates